Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion type Assertion NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_head.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion description "[A daily subcutaneous infusion of 18-base, fully phosporothioated antisense oligonucleotide was administered for 2 weeks to nine patients who had BCL-2-positive relapsed non-Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion evidence source_evidence_literature NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion SIO_000772 9113013 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion wasDerivedFrom befree-2016 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.
- NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_assertion wasGeneratedBy ECO_0000203 NP1371082.RA8Mtgutx-BtxQmDkhZ1JW5lUDp72-UMd0kPzZBnX4iEs130_provenance.